System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Massimo Volpe is an expert in Cardiology at Azienda Ospedaliera Sant'Andrea (Italy). As of October 2026, ScienceLeadR ranks Massimo Volpe in the top 1% of experts worldwide for Hypertension, Heart Failure and Cardiomyopathies. Massimo Volpe has authored 1,214 publications, the most recent in 2026, and is an investigator in 24 clinical trials, 2 of them ongoing. SLR score: 4,845 (community average: 125). How the SLR is computed.

LeadR Profile

Massimo Volpe Azienda Ospedaliera Sant'Andrea Italy
4 845 ScienceLeadR Reputation 4845

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Hematology - Nutrition - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1987 - 2026
Source: PubMed

Sapienza University of Rome

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1214

Citations

Citations: 79 641 1st author: 245 Last author: 374 Unique author: 39

Main journals

Eur Heart J 149
High Blood Press Cardiovasc Prev 136
J Hypertens 81
Int J Cardiol 53
Circulation 31

Best Journals

Eur Heart J 120
N Engl J Med 8
JAMA 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Associations of exclusive e-cigarette use and dual use of e-cigarettes and combustible cigarettes with prevalent and incident hypertension: A systematic review and meta-analysis.
PMID 42827889 — bias, hypertension, blood, classification, vaping, records, smoking		Am J Prev Cardiol20260
[Influenza vaccination as an intervention for cardiovascular prevention and protection in high-risk patients. SIPREC/ANMCO/SIMI/FADOI/ARCA consensus document].
PMID 42788302 — vaccines, cardiovascular diseases, vaccination, influenza, human		G Ital Cardiol (Rome)20260
Weekly Journal Scan: Simplifying guideline-directed medical therapy with a once-daily polypill improves treatment implementation and short-term outcomes in heart failure with reduced ejection fraction.
PMID 42690763 — heart failure, heart, cardiology, heart failure, systolic, therapeutics, single-pill combination		Eur Heart J Top journal20260
Mitofusin 2 polymorphic variants and left ventricular hypertrophy in human hypertension.
PMID 42625027 — hypertension, hypertrophy, left ventricular, hypertrophy, alleles, genotype		J Hum Hypertens20260
Weekly Journal Scan: Revisiting the role of digitalis glycosides in the management of heart failure.
PMID 42619253 — heart failure, heart, glycosides, cardiology, digitalis glycosides		Eur Heart J Top journal20260

Clinical Studies 24

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4 Study Chair: 1 Study Director: 1

By phase:

Phase 3 14
N/A 7
Phase 4 3

By status:

Completed 18
Recruiting 3
Terminated 2
Unknown 1

By type:

Interventional 19
Observational 5

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 2
multicentric5to9 0
multicentricup10 16

Main Topics

Cohort/Consortium Investigators 5

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Novel Risk Prediction Approaches for the Primary Prevention of Cardiovascular Diseases in Italy the CVRISK IT Trial (CVRISK IT)
NCT06832644 — chronic disease, life style, cardiovascular diseases, primary prevention, therapeutics, men		N/ARecruiting2025
DENEX Renal Denervation in Patients With Hypertension on no Antihypertensive Medications
NCT04535050 — pilot projects, hypertension, pilots, safety, denervation, cardiovascular diseases, angiography, antihypertensive agents, vascular diseases		N/ARecruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS